Compare Novo Nordisk A/S (NVO) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs SiTime Corporation — how do they compare? Novo Nordisk A/S trades at $38.64 (market cap $165.31B), while SiTime Corporation trades at $612.37 (market cap $19.42B). The key difference: Novo Nordisk A/S is far larger — about 8.5× SiTime Corporation's market cap, and Novo Nordisk A/S pays a 4.71% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and SiTime Corporation for 18 Days on average.
| NVO | SITM | |
|---|---|---|
Market Cap | $165.31B | $19.42B |
Volume | 11,432,838 | 360,307 |
Sector | Health | Technology |
52-Week High | $63.98 | $901.60 |
52-Week Low | $35.29 | $252.76 |
Typical Hold Time | 116 Days | 18 Days |
Enterprise Value | $179.56B | $18.82B |
Dividend Yield | 4.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.18, down 0.21% with a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (35.35% net margin, 59.82% ROE). Recent news highlights pipeline developments including Wegovy pill data and a $4 billion licensing deal, though the FDA extended review of its hemophilia drug. Cash flow remains positive at $10.81B for 2025, supporting dividend payments.
NVO presents a compelling value opportunity with a 9.66 P/E ratio and 17% upside to the $44.67 consensus target. However, competitive pressure from Eli Lilly's obesity drug pipeline and regulatory delays pose near-term risks. Analyst sentiment is bullish (59% buy ratings), but investors should monitor Q3 2026 earnings against the 0.753 EPS expectation for confirmation of growth trajectory.
SITM trades at $645.06, down 3.02% today but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $628 and $610, while fundamental metrics highlight accelerating revenue growth from $327M in 2025 to $468M in 2026, though profitability remains volatile with recent net income turning positive. Analyst sentiment remains overwhelmingly positive with 100% buy ratings and a $751.43 consensus target.
SITM presents compelling growth potential driven by AI infrastructure demand and market leadership in precision timing solutions, though investors face risks from valuation multiples and competitive pressures. The company's inflection toward profitability and strong institutional support suggest upside potential, but requires monitoring of execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
